275 related articles for article (PubMed ID: 27033541)
1. AIP mutations in young patients with acromegaly and the Tampico Giant: the Mexican experience.
Ramírez-Rentería C; Hernández-Ramírez LC; Portocarrero-Ortiz L; Vargas G; Melgar V; Espinosa E; Espinosa-de-Los-Monteros AL; Sosa E; González B; Zúñiga S; Unterländer M; Burger J; Stals K; Bussell AM; Ellard S; Dang M; Iacovazzo D; Kapur S; Gabrovska P; Radian S; Roncaroli F; Korbonits M; Mercado M
Endocrine; 2016 Aug; 53(2):402-11. PubMed ID: 27033541
[TBL] [Abstract][Full Text] [Related]
2. Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas.
Cazabat L; Libè R; Perlemoine K; René-Corail F; Burnichon N; Gimenez-Roqueplo AP; Dupasquier-Fediaevsky L; Bertagna X; Clauser E; Chanson P; Bertherat J; Raffin-Sanson ML
Eur J Endocrinol; 2007 Jul; 157(1):1-8. PubMed ID: 17609395
[TBL] [Abstract][Full Text] [Related]
3. Analysis of GPR101 and AIP genes mutations in acromegaly: a multicentric study.
Ferraù F; Romeo PD; Puglisi S; Ragonese M; Torre ML; Scaroni C; Occhi G; De Menis E; Arnaldi G; Trimarchi F; Cannavò S
Endocrine; 2016 Dec; 54(3):762-767. PubMed ID: 26815903
[TBL] [Abstract][Full Text] [Related]
4. AIP mutations and gigantism.
Rostomyan L; Potorac I; Beckers P; Daly AF; Beckers A
Ann Endocrinol (Paris); 2017 Jun; 78(2):123-130. PubMed ID: 28483363
[TBL] [Abstract][Full Text] [Related]
5. A novel truncating AIP mutation, p.W279*, in a familial isolated pituitary adenoma (FIPA) kindred.
Cansu GB; Taşkıran B; Trivellin G; Faucz FR; Stratakis CA
Hormones (Athens); 2016 Jul; 15(3):441-444. PubMed ID: 27838609
[TBL] [Abstract][Full Text] [Related]
6. A novel germline mutation in the aryl hydrocarbon receptor-interacting protein (AIP) gene in an Italian family with gigantism.
Urbani C; Russo D; Raggi F; Lombardi M; Sardella C; Scattina I; Lupi I; Manetti L; Tomisti L; Marcocci C; Martino E; Bogazzi F
J Endocrinol Invest; 2014 Oct; 37(10):949-55. PubMed ID: 24996936
[TBL] [Abstract][Full Text] [Related]
7. Frequency of AIP gene mutations in young patients with acromegaly: a registry-based study.
Schöfl C; Honegger J; Droste M; Grussendorf M; Finke R; Plöckinger U; Berg C; Willenberg HS; Lammert A; Klingmüller D; Jaursch-Hancke C; Tönjes A; Schneidewind S; Flitsch J; Bullmann C; Dimopoulou C; Stalla G; Mayr B; Hoeppner W; Schopohl J
J Clin Endocrinol Metab; 2014 Dec; 99(12):E2789-93. PubMed ID: 25093619
[TBL] [Abstract][Full Text] [Related]
8. Screening of
Tuncer FN; Çiftçi Doğanşen S; Serbest E; Tanrıkulu S; Ekici Y; Bilgiç B; Yarman S
Genet Test Mol Biomarkers; 2018 Dec; 22(12):702-708. PubMed ID: 30461320
[No Abstract] [Full Text] [Related]
9. Germline mutations of AIP gene in somatotropinomas resistant to somatostatin analogues.
Oriola J; Lucas T; Halperin I; Mora M; Perales MJ; Alvarez-Escolá C; Paz de MN; Díaz Soto G; Salinas I; Julián MT; Olaizola I; Bernabeu I; Marazuela M; Puig-Domingo M
Eur J Endocrinol; 2013 Jan; 168(1):9-13. PubMed ID: 23038625
[TBL] [Abstract][Full Text] [Related]
10. Clinical experience in the screening and management of a large kindred with familial isolated pituitary adenoma due to an aryl hydrocarbon receptor interacting protein (AIP) mutation.
Williams F; Hunter S; Bradley L; Chahal HS; Storr HL; Akker SA; Kumar AV; Orme SM; Evanson J; Abid N; Morrison PJ; Korbonits M; Atkinson AB
J Clin Endocrinol Metab; 2014 Apr; 99(4):1122-31. PubMed ID: 24423289
[TBL] [Abstract][Full Text] [Related]
11. Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients.
Rostomyan L; Daly AF; Petrossians P; Nachev E; Lila AR; Lecoq AL; Lecumberri B; Trivellin G; Salvatori R; Moraitis AG; Holdaway I; Kranenburg-van Klaveren DJ; Chiara Zatelli M; Palacios N; Nozieres C; Zacharin M; Ebeling T; Ojaniemi M; Rozhinskaya L; Verrua E; Jaffrain-Rea ML; Filipponi S; Gusakova D; Pronin V; Bertherat J; Belaya Z; Ilovayskaya I; Sahnoun-Fathallah M; Sievers C; Stalla GK; Castermans E; Caberg JH; Sorkina E; Auriemma RS; Mittal S; Kareva M; Lysy PA; Emy P; De Menis E; Choong CS; Mantovani G; Bours V; De Herder W; Brue T; Barlier A; Neggers SJ; Zacharieva S; Chanson P; Shah NS; Stratakis CA; Naves LA; Beckers A
Endocr Relat Cancer; 2015 Oct; 22(5):745-57. PubMed ID: 26187128
[TBL] [Abstract][Full Text] [Related]
12. AIP mutation in pituitary adenomas in the 18th century and today.
Chahal HS; Stals K; Unterländer M; Balding DJ; Thomas MG; Kumar AV; Besser GM; Atkinson AB; Morrison PJ; Howlett TA; Levy MJ; Orme SM; Akker SA; Abel RL; Grossman AB; Burger J; Ellard S; Korbonits M
N Engl J Med; 2011 Jan; 364(1):43-50. PubMed ID: 21208107
[TBL] [Abstract][Full Text] [Related]
13. Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients.
Cazabat L; Bouligand J; Salenave S; Bernier M; Gaillard S; Parker F; Young J; Guiochon-Mantel A; Chanson P
J Clin Endocrinol Metab; 2012 Apr; 97(4):E663-70. PubMed ID: 22319033
[TBL] [Abstract][Full Text] [Related]
14. Increased Population Risk of AIP-Related Acromegaly and Gigantism in Ireland.
Radian S; Diekmann Y; Gabrovska P; Holland B; Bradley L; Wallace H; Stals K; Bussell AM; McGurren K; Cuesta M; Ryan AW; Herincs M; Hernández-Ramírez LC; Holland A; Samuels J; Aflorei ED; Barry S; Dénes J; Pernicova I; Stiles CE; Trivellin G; McCloskey R; Ajzensztejn M; Abid N; Akker SA; Mercado M; Cohen M; Thakker RV; Baldeweg S; Barkan A; Musat M; Levy M; Orme SM; Unterländer M; Burger J; Kumar AV; Ellard S; McPartlin J; McManus R; Linden GJ; Atkinson B; Balding DJ; Agha A; Thompson CJ; Hunter SJ; Thomas MG; Morrison PJ; Korbonits M
Hum Mutat; 2017 Jan; 38(1):78-85. PubMed ID: 27650164
[TBL] [Abstract][Full Text] [Related]
15. Large-scale second-hit AIP deletion causing a pediatric growth hormone-secreting pituitary adenoma: Case report and review of literature.
Gummadavelli A; Dinauer C; McGuone D; Vining EM; Erson-Omay EZ; Omay SB
J Clin Neurosci; 2020 Aug; 78():420-422. PubMed ID: 32336638
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of AIP mutations in a large series of sporadic Italian acromegalic patients and evaluation of CDKN1B status in acromegalic patients with multiple endocrine neoplasia.
Occhi G; Trivellin G; Ceccato F; De Lazzari P; Giorgi G; Demattè S; Grimaldi F; Castello R; Davì MV; Arnaldi G; Salviati L; Opocher G; Mantero F; Scaroni C
Eur J Endocrinol; 2010 Sep; 163(3):369-76. PubMed ID: 20530095
[TBL] [Abstract][Full Text] [Related]
17. The aryl hydrocarbon receptor-interacting protein gene is rarely mutated in sporadic GH-secreting adenomas.
Iwata T; Yamada S; Mizusawa N; Golam HM; Sano T; Yoshimoto K
Clin Endocrinol (Oxf); 2007 Apr; 66(4):499-502. PubMed ID: 17371465
[TBL] [Abstract][Full Text] [Related]
18. Familial acromegaly due to aryl hydrocarbon receptor-interacting protein (AIP) gene mutation in a Turkish cohort.
Niyazoglu M; Sayitoglu M; Firtina S; Hatipoglu E; Gazioglu N; Kadioglu P
Pituitary; 2014 Jun; 17(3):220-6. PubMed ID: 23743763
[TBL] [Abstract][Full Text] [Related]
19. Genetic and clinical characteristics of Japanese patients with sporadic somatotropinoma.
Matsumoto R; Izawa M; Fukuoka H; Iguchi G; Odake Y; Yoshida K; Bando H; Suda K; Nishizawa H; Takahashi M; Inoshita N; Yamada S; Ogawa W; Takahashi Y
Endocr J; 2016 Nov; 63(11):953-963. PubMed ID: 27498687
[TBL] [Abstract][Full Text] [Related]
20. RET signalling provides tumorigenic mechanism and tissue specificity for AIP-related somatotrophinomas.
Garcia-Rendueles AR; Chenlo M; Oroz-Gonjar F; Solomou A; Mistry A; Barry S; Gaston-Massuet C; Garcia-Lavandeira M; Perez-Romero S; Suarez-Fariña M; Pradilla-Dieste A; Dieguez C; Mehlen P; Korbonits M; Alvarez CV
Oncogene; 2021 Nov; 40(45):6354-6368. PubMed ID: 34588620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
